Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBOXETINE vs RELUGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REBOXETINE vs RELUGOLIX: Safety Overview

Metric REBOXETINE RELUGOLIX
Total FAERS Reports 185 20,660
Deaths Reported 19 958
Death Rate 10.3% 4.6%
Hospitalizations 63 1,699
Average Patient Age 53.6 yrs 72.4 yrs
% Female Patients 62.7% 1.4%
FDA Approval Date N/A Dec 18, 2020
Manufacturer N/A Sumitomo Pharma America, Inc.
Route N/A ORAL
Marketing Status N/A Prescription